Hypofractionated Radiation Therapy Versus Conventional Radiation Therapy in Patients With Intermediate- to High-Risk Localized Prostate Cancer

被引:0
|
作者
Guo, W. [1 ]
Gao, X. S. [1 ]
Gu, X. [1 ]
Ma, M. [1 ]
机构
[1] Peking Univ, Hosp 1, Dept Radiat Oncol, Beijing, Peoples R China
关键词
D O I
10.1016/j.ijrobp.2017.06.1169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2567
引用
收藏
页码:E236 / E237
页数:2
相关论文
共 50 条
  • [31] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
    Lara, Pedro C.
    Rodriguez-Melcon, Juan I.
    Palacios-Eito, Amalia
    Lozano, Antonio
    Hervas-Moron, Asuncion
    Villafranca, Elena
    Gomez-Iturriaga, Alfonso
    Sancho, Gemma
    Maldonado, Xavier
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
    Weber, Damien C.
    Tille, Jean-Christophe
    Combescure, Christophe
    Egger, Jean-Francois
    Laouiti, Mahomet
    Hammad, Karim
    Granger, Perrine
    Rubbia-Brandt, Laura
    Miralbell, Raymond
    [J]. RADIATION ONCOLOGY, 2012, 7
  • [34] The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
    Damien C Weber
    Jean-Christophe Tille
    Christophe Combescure
    Jean-François Egger
    Mahomet Laouiti
    Karim Hammad
    Perrine Granger
    Laura Rubbia-Brandt
    Raymond Miralbell
    [J]. Radiation Oncology, 7
  • [35] Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study
    Sasamura, Kazuma
    Soyano, Takashi
    Kozuka, Takuyo
    Yuasa, Takeshi
    Yamamoto, Shinya
    Yonese, Junji
    Oguchi, Masahiko
    Yoshimura, Ryoichi
    Yoshioka, Yasuo
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (02) : 170 - 178
  • [36] Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer
    Zapatero, A.
    Guerrero, A.
    Maldonado, J.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M.
    Macias, V.
    Pedro-Olive, A.
    Casas, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M.
    Calvo, F. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S1 - S1
  • [37] Management of high-risk prostate cancer: Radiation therapy and hormonal therapy
    Nomiya, Takuma
    Tsuji, Hiroshi
    Toyama, Shingo
    Maruyama, Katsuya
    Nemoto, Kenji
    Tsujii, Hirohiko
    Kamada, Tadashi
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (08) : 872 - 878
  • [38] High Dose Rate Brachytherapy With Hypofractionated External Beam Radiation Therapy for High-Risk Prostate Cancer
    Ishii, Y.
    Hashimoto, Y.
    Kono, S.
    Izumi, S.
    Iizuka, J.
    Karasawa, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E241 - E241
  • [39] Analysis of Rectal Bleeding Risk with Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer
    McHaffie, Derek
    Adkison, Jarred
    Patel, Rakesh
    Khuntia, Deepak
    Ritter, Mark
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 108 - 109
  • [40] 10-Year Update of a Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer
    Avkshtol, V.
    Li, T.
    Hallman, M. A.
    Greenberg, R.
    Price, R. A., Jr.
    Uzzo, R. G.
    Ma, C. M. C.
    Chen, D.
    Geynisman, D. M.
    Pollack, A.
    Horwitz, E. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S30 - S31